Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Seminars in Urologic Oncology|September 20, 2001
Complications of chemotherapy for prostate cancerT M Beer, J S BubaloCancer|June 20, 2001
A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalationT M Beer, M Munar, W D HennerCurrent Oncology Reports|August 8, 2001
Allogeneic stem-cell transplantation in renal-cell carcinomaB M Hayes-Lattin, R T Maziarz, T M BeerUrology|May 12, 2004
Imatinib mesylate and zoledronic acid in androgen-independent prostate cancerN M Tiffany, E M Wersinger, M Garzotto, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancerT M Beer, W C Pierce, B A Lowe, et al.British Journal of Cancer|September 11, 2003
Intermittent chemotherapy in metastatic androgen-independent prostate cancerT M Beer, M Garzotto, W D Henner, et al.British Journal of Cancer|October 7, 2004
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancerT M Beer, M Garzotto, W D Henner, et al.Investigational New Drugs|October 10, 2008
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancerC D Blanke, T M Beer, K Todd, et al.Seminars in Oncology|October 31, 2001
Weekly high-dose calcitriol and docetaxel in advanced prostate cancerT M Beer, K M Hough, M Garzotto, et al.Prostate Cancer and Prostatic Diseases|January 4, 2017
Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trialsF Saad, C Ivanescu, D Phung, et al.Pageof 3